The Role of SGLT2 Inhibitors in HFrEF Care: What Do the Latest Clinical Practice Documents Say?

Drs Zieroth, Coats, and Januzzi discuss the latest recommendations regarding SGLT2 inhibitors in HFrEF management. Credit available for this activity expires: [06/18/22] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/953116?src=mkm_podcast_addon_953116